Pharmaceuticals, Biotechnology and Life Sciences
– Beyond expectations, a single injection of DNA in mice induced antibodies that block the infection of cultured human cells…
LONDON–(BUSINESS WIRE)–#EAACI2019–Stallergenes Greer, a biopharmaceutical company specialising in treatments for respiratory allergies, announces the submission of a marketing authorisation application…
LYON, France & STRASBOURG, France–(BUSINESS WIRE)–$TNG–Regulatory News: Vaxxel SAS, a French start-up, developing vaccines against respiratory viral infections, announces the…
PARIS & MONTREAL–(BUSINESS WIRE)–Regulatory News: Ipsen (Euronext: IPN; ADR: IPSEY), a global specialty-driven biopharmaceutical group, IRICoR, a pan-Canadian research commercialization…
AbCellera’s world-leading drug discovery technology identifies antibodies for potential use in drugs to treat and prevent COVID-19 got cash support from Canadian Government of $175.6 million.
Gilead get’s authorization of emergency use of Remdesivir to treat hospitalized patients with severe COVID-19 disease in the United States.
PASADENA, Calif.–(BUSINESS WIRE)–$arwr–Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) today announced the retirement of Bruce Given, M.D., Arrowhead’s chief operating officer and…
Revance, Mylan Biosimilar to Botox postpon program decision to aftr April
ST. PAUL, Minn.–(BUSINESS WIRE)–3M today announced that it has completed the sale of substantially all of its drug delivery business…
Moderna has engaged with Lonza to work on its novel coronavirus vaccine, with a goal to enable manufacturing of up to 1 billion doses per year, noting that technology transfer is expected to begin in June 2020.